BioCryst Pharmaceuticals, Inc. (BCRX)
9.83
+0.15
(+1.55%)
USD |
NASDAQ |
Aug 25, 16:00
9.845
+0.02
(+0.15%)
After-Hours: 19:59
BioCryst Pharmaceuticals Price : 9.83 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 9.79 | 9.916 | 9.698 | 9.83 | 2.333M |
| Aug 24, 2026 | 9.50 | 9.755 | 9.48 | 9.68 | 2.010M |
| Aug 21, 2026 | 9.72 | 9.905 | 9.48 | 9.55 | 2.497M |
| Aug 20, 2026 | 9.92 | 9.988 | 9.595 | 9.66 | 2.329M |
| Aug 19, 2026 | 9.93 | 10.11 | 9.765 | 10.07 | 2.907M |
| Aug 18, 2026 | 9.89 | 9.94 | 9.545 | 9.70 | 2.122M |
| Aug 17, 2026 | 9.72 | 10.02 | 9.65 | 9.94 | 2.123M |
| Aug 14, 2026 | 9.68 | 9.800 | 9.46 | 9.74 | 3.821M |
| Aug 13, 2026 | 10.59 | 10.63 | 9.70 | 9.81 | 4.583M |
| Aug 12, 2026 | 10.33 | 10.68 | 10.10 | 10.59 | 3.866M |
| Aug 11, 2026 | 9.86 | 10.59 | 9.78 | 10.34 | 5.034M |
| Aug 10, 2026 | 9.33 | 9.855 | 9.280 | 9.84 | 4.017M |
| Aug 07, 2026 | 9.50 | 9.665 | 9.23 | 9.38 | 4.384M |
| Aug 06, 2026 | 9.04 | 9.53 | 8.98 | 9.30 | 4.044M |
| Aug 05, 2026 | 9.44 | 9.67 | 8.805 | 9.07 | 6.094M |
| Aug 04, 2026 | 8.82 | 9.04 | 8.76 | 9.02 | 2.921M |
| Aug 03, 2026 | 9.00 | 9.075 | 8.77 | 8.81 | 3.190M |
| Jul 31, 2026 | 9.17 | 9.25 | 8.925 | 8.98 | 2.929M |
| Jul 30, 2026 | 9.44 | 9.50 | 9.15 | 9.24 | 2.323M |
| Jul 29, 2026 | 9.66 | 9.79 | 9.505 | 9.53 | 2.195M |
| Jul 28, 2026 | 9.64 | 9.785 | 9.505 | 9.74 | 2.875M |
| Jul 27, 2026 | 9.64 | 9.91 | 9.58 | 9.58 | 4.311M |
| Jul 24, 2026 | 9.41 | 9.485 | 9.295 | 9.34 | 1.852M |
| Jul 23, 2026 | 9.32 | 9.480 | 9.25 | 9.38 | 1.635M |
| Jul 22, 2026 | 9.37 | 9.69 | 9.36 | 9.51 | 2.550M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 442.24 |
| Vertex Pharmaceuticals, Inc. | 552.85 |
| Agenus, Inc. | 8.36 |
| Anika Therapeutics, Inc. | 21.40 |
| Imunon, Inc. | 1.66 |
Price Related Metrics
| PS Ratio | 2.473 |
| PEG Ratio | -0.0085 |
| Price to Free Cash Flow | 6.53 |
| Earnings Yield | -15.30% |
| Market Cap | 2.509B |
| PEGY Ratio | -0.0085 |
| Operating PE Ratio | 6.048 |
| Normalized PE Ratio | 17.60 |